These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 15198439)

  • 21. microRNAs: key modulators of disease-modifying therapies in multiple sclerosis.
    Ehtesham N; Mosallaei M; Karimzadeh MR; Moradikazerouni H; Sharifi M
    Int Rev Immunol; 2020; 39(6):264-279. PubMed ID: 32552273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using MRI to make informed clinical decisions in multiple sclerosis care.
    Bermel RA; Naismith RT
    Curr Opin Neurol; 2015 Jun; 28(3):244-9. PubMed ID: 25887772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advanced magnetic resonance imaging metrics: implications for multiple sclerosis clinical trials.
    Zivadinov R
    Methods Find Exp Clin Pharmacol; 2009; 31(1):29-40. PubMed ID: 19357796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Established and novel disease-modifying treatments in multiple sclerosis.
    Cross AH; Naismith RT
    J Intern Med; 2014 Apr; 275(4):350-63. PubMed ID: 24444048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review of methodological issues of clinical trials in multiple sclerosis.
    Montalban X
    J Neurol Sci; 2011 Dec; 311 Suppl 1():S35-42. PubMed ID: 22206765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
    Ball S; Vickery J; Hobart J; Wright D; Green C; Shearer J; Nunn A; Cano MG; MacManus D; Miller D; Mallik S; Zajicek J
    Health Technol Assess; 2015 Feb; 19(12):vii-viii, xxv-xxxi, 1-187. PubMed ID: 25676540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Canadian Expert Panel Recommendations for MRI Use in MS Diagnosis and Monitoring.
    Traboulsee A; Létourneau-Guillon L; Freedman MS; O'Connor PW; Bharatha A; Chakraborty S; Girard JM; Giuliani F; Lysack JT; Marriott JJ; Metz LM; Morrow SA; Oh J; Sharma M; Vandorpe RA; Vertinsky TA; Wadhwa VS; von Riedemann S; Li DK
    Can J Neurol Sci; 2015 May; 42(3):159-67. PubMed ID: 25896163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting and preventing the future: actively managing multiple sclerosis.
    Hutchinson M
    Pract Neurol; 2009 Jun; 9(3):133-43, discussion 144. PubMed ID: 19448055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis.
    La Mantia L; Di Pietrantonj C; Rovaris M; Rigon G; Frau S; Berardo F; Gandini A; Longobardi A; Weinstock-Guttman B; Vaona A
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD009333. PubMed ID: 27880972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Consensus recommendations on the management of multiple sclerosis patients in Argentina.
    Cristiano E; Rojas JI; Alonso R; Alvez Pinheiro A; Bacile EA; Balbuena ME; Barboza AG; Bestoso S; Burgos M; Cáceres F; Carnero Contentti E; Curbelo MC; Deri N; Fernandez Liguori N; Gaitán MI; Garcea O; Giunta D; Halfon MJ; Hryb JP; Jacobo M; Kohler E; Luetic GG; Maglio I; Martínez AD; Míguez J; Nofal PG; Patrucco L; Piedrabuena R; Rotta Escalante R; Saladino ML; Silva BA; Sinay V; Tkachuk V; Villa A; Vrech C; Ysrraelit MC; Correale J
    J Neurol Sci; 2020 Feb; 409():116609. PubMed ID: 31816524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimizing treatment success in multiple sclerosis.
    Ziemssen T; Derfuss T; de Stefano N; Giovannoni G; Palavra F; Tomic D; Vollmer T; Schippling S
    J Neurol; 2016 Jun; 263(6):1053-65. PubMed ID: 26705122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current therapeutic recommendations in multiple sclerosis.
    Berger T
    J Neurol Sci; 2009 Dec; 287 Suppl 1():S37-45. PubMed ID: 20106347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunization and multiple sclerosis: Recommendations from the French multiple sclerosis society.
    Lebrun C; Vukusic S;
    Mult Scler Relat Disord; 2019 Jun; 31():173-188. PubMed ID: 31159998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management strategies for female patients of reproductive potential with multiple sclerosis: An evidence-based review.
    Coyle PK; Oh J; Magyari M; Oreja-Guevara C; Houtchens M
    Mult Scler Relat Disord; 2019 Jul; 32():54-63. PubMed ID: 31030020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Issues and practices in multiple sclerosis.
    Burks JS; Arnason BG; Coyle PK; Ford CC; Noronha A; Rammohan KW
    Neurorehabil Neural Repair; 2002 Dec; 16(4):307-20. PubMed ID: 12462762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toward a Shared-Care Model of Relapsing-Remitting Multiple Sclerosis: Role of the Primary Care Practitioner.
    Oh J; Gagné-Brosseau MS; Guenette M; Larochelle C; Lemieux F; Menon S; Morrow SA; Poliquin-Lasnier L; Roy-Hewitson C; Rush C; Trudelle AM; Giacomini PS
    Can J Neurol Sci; 2018 May; 45(3):304-312. PubMed ID: 29756588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted clinical audits immediately following the establishment of clinical practice guidelines for multiple sclerosis in 17 neurology departments: A pragmatic and collaborative study.
    Lairy G; Zephir H; Ouallet JC; Le Page E; Laplaud D; Bensa C; De Seze J
    Rev Neurol (Paris); 2015 May; 171(5):407-14. PubMed ID: 25912471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The role of MRI in measuring the effectivity of disease modifying treatments II].
    Kincses Z; Tóth E; Fricska-Nagy Z; Füvesi J; Rajda C; Bencsik K; Vörös E; Csomor A; Palkó A; Vécsei L
    Ideggyogy Sz; 2018 Mar; 71(3-04):81-88. PubMed ID: 29889466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome measures in multiple sclerosis clinical trials.
    Andersson PB; Goodkin DE
    Baillieres Clin Neurol; 1997 Oct; 6(3):409-28. PubMed ID: 10101581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The role of MRI in measuring the effectivity of disease modifying treatments I].
    Tóth E; Bencsik K; Vörös E; Fricska-Nagy Z; Füvesi J; Rajda C; Csomor A; Palkó A; Vécsei L; Kincses ZT
    Ideggyogy Sz; 2018 Mar; 71(3-04):77-80. PubMed ID: 29889465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.